Toews Corporation’s Gilead Sciences GILD Stock Holding History

Toews Corporation’s Portfolio GILD Stock Details GILD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$19K	Buy	+150	New	+$19.8K	﹤0.01%	118
2023 Q1	–	Sell	-9,100	Closed	-$781K	–	59
2022 Q4	$781K	Sell	9,100 -9,200	-50%	-$729K	0.39%	39
2022 Q3	$1.13M	Sell	18,300 -2,100	-10%	-$132K	0.83%	19
2022 Q2	$1.26M	Buy	20,400 +13,600	+200%	+$842K	0.84%	13
2022 Q1	$404K	Buy	+6,800	New	+$435K	0.07%	70
2021 Q4	–	Sell	-5,900	Closed	-$412K	–	62
2021 Q3	$412K	Buy	+5,900	New	+$414K	0.05%	43
2021 Q2	–	Sell	-14,500	Closed	-$937K	–	61
2021 Q1	$937K	Buy	+14,500	New	+$935K	0.08%	82
2020 Q4	–	Sell	-15,400	Closed	-$973K	–	60
2020 Q3	$973K	Buy	+15,400	New	+$1.07M	0.29%	94

Other funds holding GILD

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Toews Corporation's GILD Position: Q2 2026 in Review

Toews Corporation opened a new position in Gilead Sciences (GILD) in Q2 2026: 150 shares worth $19K. The stake represents ﹤0.01% of the portfolio and ranks #118 among its holdings. This is a return to the name: Toews Corporation previously reported a position in GILD as recently as Q4 2022.

Toews Corporation first reported a position in GILD in Q3 2020 and has held it in 8 quarters since. The position peaked at $1.26M in Q2 2022. 2,283 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

Toews Corporation held 150 shares of Gilead Sciences worth $19K as of Q2 2026.
Gilead Sciences was a new Toews Corporation position in Q2 2026.
Gilead Sciences made up ﹤0.01% of Toews Corporation's portfolio in Q2 2026, its #118 holding.
Toews Corporation first reported a position in Gilead Sciences in Q3 2020 and has held it in 8 quarters since.
Toews Corporation's Gilead Sciences position peaked at $1.26M in Q2 2022.
2,283 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on Toews Corporation's 13F filing for Q2 2026, filed 10 Aug 2026.